-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
On the morning of August 20, the third national drug centralized procurement opened in Shanghai, involving 56 varieties and 82 product regulations.
, including malignant tumors, hypertension, diabetes, mental illness and other fields, nearly 200 pharmaceutical companies participated in the tender.
, some of the data on the scene has flowed out, the author of this four bright spots combing, only for industry reference.
a number of foreign-owned varieties due to higher than the price limit early exit from the scene of part of the data, Lilly's original drug O nitrogen flat-mouth collapse tablets 5mg, 7 tablets per box, quoted 129.91 yuan, for 18.56 yuan / piece.
0.5g, 12 tablets per box, priced at 298 yuan, for 24.83 yuan per tablet.... As well as AstraZeneca's Anacura, Mercado's dichloretadine, Xi'an Jansen's dopanlidone, Novarhua's lamequdin, GSK's Ramifeddine, Pfizer's Shequlin, Xi'an Jansen's Prukkabili, etc., these foreign companies have been out of the market because of higher than the effective declared price.
it is understood that otolpin is an atypical antipsychotic drug used for long-term treatment of schizophrenia.
In accordance with the insight database, this time in addition to the original pharmaceutical company Lilly, there are Qilu Pharmaceuticals, Hebei Longhai Pharmaceuticals, Zhejiang Huahai Pharmaceuticals, Guangdong Dongsian Pharmaceuticals, Jiangsu Haussen Pharmaceuticals 5 enterprises to participate in the tender for Ao Nitrogen Flat mouth collapse tablets.
, Jiangsu Haussen is the first imitation.
news that this time there are two psychotrophic drugs Shetlin hydrochloric acid tablets and otoxine flat-mouthed tablets with excellent prices to win the bid.
some of the collection varieties price reduction is huge in this collection, some varieties out of the quotation data show a huge decline.
For example, the injection of azazine in this round of mining companies including Xinji, Zheng Datianqing and Sichuan Huiyu, the three companies quoted 736.5, 346 and 260, according to the rules of the three companies, Sichuan Huiyu and Zheng daqing successfully won the bid, compared with the high effective declaration price, the two companies bid down 74% and 65%, respectively.
North China Pharmaceutical's ibuprofen slow release capsule 0.3g, 30 capsules / box, quote 8.04 yuan / box, or 0.268 yuan / grain, Zhuhai Rundu Pharmaceuticals 0.2025 yuan / grain.
it is understood that the winning bid price of 0.3g of ibuprofen slow release capsules is above 0.5 yuan / tablet, according to the price of this North China Pharmaceutical, a decline of nearly 50%.
2018, China's public medical institutions terminal ibuprofen capsule sales of nearly 400 million yuan.
sugar-lowering drug metformin in the country has more than 5 billion yuan of large-scale market, the intensity of the competition is beyond imagination.
It is understood that in the morning of August 20, the actual quotation, the attention of the hydrochloric acid metformin slow release tablets 0.5g to high effective quotation 0.34 yuan, of which the stone medicine Oyi, Shanghai Shanghai Medicine Xinyi Pharmaceuticals, Qingdao Baiyang Pharmaceuticals and Qinghai Huanghai Pharmaceuticals, respectively, quoted 0.085 yuan, 0.2997 yuan, 0.39 yuan and 0.303 yuan.
addition, metformin hydrochloride slow release tablet 0.25g, to a high effective declared price of 0.2 yuan, of which Chongqing Core Pharmaceuticals quoted 0.0154 yuan, Shanghai Xinyi Balance Pharmaceuticals quoted 0.01333 yuan, stone medicine Europe quoted 0.0567 yuan.
, the two rules of the hydrochloric acid trimethyl metformin slow release film, the high price reduction range of more than 90%.
there are pharmaceutical companies for the successful bidding at any cost to open the "floor price" of this collection of competitive intensity can be seen, in order to successfully bid, some pharmaceutical companies even at the expense of the "floor price."
e.g. in this collection, theacid WestInafi bidding enterprises have Pfizer, Guangzhou Baiyunshan, Qilu, Yabang Epson four enterprises, the result of Qilu Pharmaceuticals with more than 3 pieces of successful bid, the rest of the enterprises out.
it isthat sic acid sedina is an erectile dysfunction.
2018 sales ofacid sedina tablets in China's public hospitals and urban retail pharmacies were RMB114 million and RMB2,207 million, respectively, according to data from the
-meter intranet.
some pharmaceutical companies collected varieties all winning the bid on the same day, there have been pharmaceutical companies out of the collection of all the winning varieties of good news.
e.g., The sodium bicarbonate tablets of Great Medicine (0.5g x 100 tablets), the hydrochloric acid quamide tablets (20mg x 60 tablets), the non-amine tablets (5mg x 28 tablets) and the Catopri tablets (25mg x 100 tablets) all received consistent evaluation of the product.
said that the above four products will help expand the proportion of sales of these products in the domestic market, improve the brand influence of doctors and patients.
.